{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T03:47:37Z","timestamp":1784951257232,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.jmb.2005.04.072","type":"journal-article","created":{"date-parts":[[2005,6,3]],"date-time":"2005-06-03T11:36:51Z","timestamp":1117798611000},"page":"416-426","source":"Crossref","is-referenced-by-count":104,"title":["Inhibition of Myotoxic Activity of Bothrops asper Myotoxin II by the Anti-trypanosomal Drug Suramin"],"prefix":"10.1016","volume":"350","author":[{"given":"M\u00e1rio T.","family":"Murakami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emerson Z.","family":"Arruda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo A.","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana B.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabri\u0144a","family":"Calil-Eli\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo A.","family":"Tomaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Lomonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghuvir K.","family":"Arni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2005.04.072_bib1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4269\/ajtmh.1951.s1-31.617","article-title":"Experimental therapy of onchocerciasis with suramin and hetrazan; results of a three-year study","volume":"31","author":"Burch","year":"1951","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jmb.2005.04.072_bib2","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/1771074a0","article-title":"Prophylactic activity of suramin complexes in animal trypanosomiasis","volume":"177","author":"Williamson","year":"1956","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2005.04.072_bib3","first-page":"550","article-title":"The treatment of onchocerciasis","volume":"37","author":"Cherry","year":"1960","journal-title":"East. Afr. Med. J."},{"key":"10.1016\/j.jmb.2005.04.072_bib4","first-page":"763","article-title":"Treatment of human African trypanosomiasis","volume":"28","author":"Schneider","year":"1963","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.jmb.2005.04.072_bib5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0094-0143(21)01399-9","article-title":"Use of suramin in treatment of prostatic carcinoma refractory to conventional hormonal manipulation","volume":"18","author":"LaRocca","year":"1991","journal-title":"Urol. Clin. North Am."},{"key":"10.1016\/j.jmb.2005.04.072_bib6","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0277-5379(91)90180-L","article-title":"Phase II clinical trial of doxifluridine in patients with advanced ovarian cancer","volume":"27","author":"van Oosterom","year":"1991","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jmb.2005.04.072_bib7","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1006\/jmcc.1996.0142","article-title":"Suramin is a potent inhibitor of vascular endothelial growth factor. A contribution to the molecular basis of its antiangiogenic action","volume":"28","author":"Waltenberger","year":"1996","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.jmb.2005.04.072_bib8","doi-asserted-by":"crossref","first-page":"9950","DOI":"10.1074\/jbc.272.15.9950","article-title":"Inhibition of neutrophil serine proteinases by suramin","volume":"272","author":"Cadene","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2005.04.072_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1023\/A:1009244623717","article-title":"Conformational requirements of suramin to target angiogenic growth factors","volume":"2","author":"Raj","year":"1998","journal-title":"Angiogenesis"},{"key":"10.1016\/j.jmb.2005.04.072_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0014-5793(03)00488-5","article-title":"Kinetics of inhibition of sperm beta-acrosin activity by suramin","volume":"544","author":"Hermans","year":"2003","journal-title":"FEBS Letters"},{"key":"10.1016\/j.jmb.2005.04.072_bib11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1383-5769(02)00044-2","article-title":"Human African trypanosomiasis: potential therapeutic benefits of an alternative suramin and melarsoprol regimen","volume":"51","author":"Jennings","year":"2002","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.jmb.2005.04.072_bib12","doi-asserted-by":"crossref","first-page":"47670","DOI":"10.1074\/jbc.M306603200","article-title":"Suramin and suramin analogues inhibit merozoite surface protein-1 secondary processing and erythrocyte invasion by the malaria parasite Plasmodium falciparum","volume":"278","author":"Fleck","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2005.04.072_bib13","doi-asserted-by":"crossref","first-page":"14713","DOI":"10.1074\/jbc.M312488200","article-title":"Suramin derivatives as inhibitors and activators of protein-tyrosine phosphatases","volume":"279","author":"McCain","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2005.04.072_bib14","doi-asserted-by":"crossref","first-page":"21774","DOI":"10.1074\/jbc.M212833200","article-title":"Leads for development of new naphthalenesulfonate derivatives with enhanced antiangiogenic activity: crystal structure of acidic fibroblast growth factor in complex with 5-amino-2-naphthalene sulfonate","volume":"278","author":"Fernandez-Tornero","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2005.04.072_bib15","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1590\/S0100-879X2002000600013","article-title":"Effect of suramin on myotoxicity of some crotalid snake venoms","volume":"35","author":"Arruda","year":"2002","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.jmb.2005.04.072_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0041-0101(03)00166-1","article-title":"Antagonism of myotoxic and paralyzing activities of bothropstoxin-I by suramin","volume":"42","author":"de Oliveira","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.jmb.2005.04.072_bib17","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0041-0101(96)00036-0","article-title":"Phospholipase A2\u2014a structural review","volume":"34","author":"Arni","year":"1996","journal-title":"Toxicon"},{"key":"10.1016\/j.jmb.2005.04.072_bib18","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.toxicon.2003.11.002","article-title":"Excitement ahead: structure, function and mechanism of snake venom phospholipase A2 enzymes","volume":"42","author":"Kini","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.jmb.2005.04.072_bib19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0163-7258(90)90081-C","article-title":"Myotoxic components of snake venoms: their biochemical and biological activities","volume":"48","author":"Mebs","year":"1990","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.jmb.2005.04.072_bib20","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/(SICI)1097-0134(19980301)30:4<442::AID-PROT11>3.0.CO;2-I","article-title":"Crystallographic and spectroscopic characterization of a molecular hinge: conformational changes in bothropstoxin I, a dimeric Lys49-phospholipase A2 homologue","volume":"30","author":"da Silva Giotto","year":"1998","journal-title":"Proteins: Struct. Funct. Genet."},{"key":"10.1016\/j.jmb.2005.04.072_bib21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0041-0101(94)90207-0","article-title":"Inhibition of the myotoxic and hemorrhagic activities of crotalid venoms by Eclipta prostrata (Asteraceae) extracts and constituents","volume":"32","author":"Melo","year":"1994","journal-title":"Toxicon"},{"key":"10.1016\/j.jmb.2005.04.072_bib22","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1126\/science.2274788","article-title":"Crystal structure of bee-venom phospholipase A2 in a complex with a transition-state analogue","volume":"250","author":"Scott","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.jmb.2005.04.072_bib23","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.toxicon.2003.11.014","article-title":"A structure based model for liposome disruption and the role of catalytic activity in myotoxic phospholipase A2s","volume":"42","author":"Murakami","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.jmb.2005.04.072_bib24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1107\/S0907444994011455","article-title":"Structure of a calcium-independent phospholipase-like myotoxic protein from Bothrops asper venom","volume":"51","author":"Arni","year":"1995","journal-title":"Acta Crystallog. sect. D"},{"key":"10.1016\/j.jmb.2005.04.072_bib25","doi-asserted-by":"crossref","first-page":"7326","DOI":"10.1074\/jbc.M410588200","article-title":"A molecular mechanism for Lys49-phospholipase A2 activity based on ligand-induced conformational change","volume":"280","author":"Ambrosio","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2005.04.072_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.biochi.2004.11.005","article-title":"Structural insights for fatty acid binding in a Lys49-phospholipase A(2): crystal structure of myotoxin II from Bothrops moojeni complexed with stearic acid","volume":"87","author":"Watanabe","year":"2005","journal-title":"Biochimie"},{"key":"10.1016\/j.jmb.2005.04.072_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1021\/bi0010470","article-title":"Structural basis for low catalytic activity in Lys49 phospholipases A2\u2014a hypothesis: the crystal structure of piratoxin II complexed to fatty acid","volume":"40","author":"Lee","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2005.04.072_bib28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0041-0101(03)00149-1","article-title":"Comparative study of synthetic peptides corresponding to region 115\u2013129 in Lys49 myotoxic phospholipases A2 from snake venoms","volume":"42","author":"Lomonte","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.jmb.2005.04.072_bib29","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.toxicon.2003.11.008","article-title":"An overview of lysine-49 phospholipase A2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action","volume":"42","author":"Lomonte","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.jmb.2005.04.072_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1042\/0264-6021:3620089","article-title":"Active-site mutagenesis of a Lys49-phospholipase A2: biological and membrane-disrupting activities in the absence of catalysis","volume":"362","author":"Ward","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.jmb.2005.04.072_bib31","first-page":"548","article-title":"Release of creatine kinase from skeletal muscles by Bothrops venoms: heparin potentiation of inhibition by antivenin","volume":"21","author":"Melo","year":"1988","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.jmb.2005.04.072_bib32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0041-0101(88)90140-7","article-title":"Release of sarcoplasmic enzymes from skeletal muscle by Bothrops jararacussu venom: antagonism by heparin and by the serum of South American marsupials","volume":"26","author":"Melo","year":"1988","journal-title":"Toxicon"},{"key":"10.1016\/j.jmb.2005.04.072_bib33","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/0006-2952(94)90525-8","article-title":"Neutralization of the cytolytic and myotoxic activities of phospholipases A2 from Bothrops asper snake venom by glycosaminoglycans of the heparin\/heparan sulfate family","volume":"47","author":"Lomonte","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jmb.2005.04.072_bib34","doi-asserted-by":"crossref","first-page":"29867","DOI":"10.1016\/S0021-9258(18)43961-0","article-title":"Neutralizing interaction between heparins and myotoxin II, a lysine 49 phospholipase A2 from Bothrops asper snake venom. Identification of a heparin-binding and cytolytic toxin region by the use of synthetic peptides and molecular modeling","volume":"269","author":"Lomonte","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2005.04.072_bib35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0041-0101(93)90146-A","article-title":"Antagonism of the myotoxic effects of Bothrops jararacussu venom and bothropstoxin by polyanions","volume":"31","author":"Melo","year":"1993","journal-title":"Toxicon"},{"key":"10.1016\/j.jmb.2005.04.072_bib36","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0167-4838(89)90218-5","article-title":"Primary structure of ammodytoxin C further reveals the toxic site of ammodytoxin","volume":"999","author":"Krizaj","year":"1989","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jmb.2005.04.072_bib37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/abbi.1996.0042","article-title":"Sequence analysis of Lys49 phospholipase A2 myotoxins: a highly conserved class of proteins","volume":"326","author":"Selistre de Araujo","year":"1996","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jmb.2005.04.072_bib38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/protein\/11.4.285","article-title":"Sequence space analysis of Lys49 phopholipases A2: clues towards identification of residues involved in a novel mechanism of membrane damage and in myotoxicity","volume":"11","author":"Ward","year":"1998","journal-title":"Protein Eng."},{"key":"10.1016\/j.jmb.2005.04.072_bib39","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0041-0101(86)90090-5","article-title":"Structure-function relationships of phospholipases. II: charge density distribution and the myotoxicity of presynaptically neurotoxic phospholipases","volume":"24","author":"Kini","year":"1986","journal-title":"Toxicon"},{"key":"10.1016\/j.jmb.2005.04.072_bib40","doi-asserted-by":"crossref","first-page":"9209","DOI":"10.1021\/bi00449a037","article-title":"Role of cationic residues in cytolytic activity: modification of lysine residues in the cardiotoxin from Naja nigricollis venom and correlation between cytolytic and antiplatelet activity","volume":"28","author":"Kini","year":"1989","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2005.04.072_bib41","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/(SICI)1099-1352(200001\/02)13:1<14::AID-JMR484>3.0.CO;2-F","article-title":"Membrane-perturbing activity of Viperidae myotoxins: an electrostatic surface potential approach to a puzzling problem","volume":"13","author":"Falconi","year":"2000","journal-title":"J. Mol. Recogn."},{"key":"10.1016\/j.jmb.2005.04.072_bib42","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0300-9084(00)01150-0","article-title":"Myotoxic phospholipases A(2) in Bothrops snake venoms: effect of chemical modifications on the enzymatic and pharmacological properties of bothropstoxins from Bothrops jararacussu","volume":"82","author":"Andri\u00e3o-Escarso","year":"2000","journal-title":"Biochimie"},{"key":"10.1016\/j.jmb.2005.04.072_bib43","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1006\/abbi.2000.2244","article-title":"Dissociation of enzymatic and pharmacological properties of piratoxins-I and -III, two myotoxic phospholipases A2 from Bothrops pirajai snake venom","volume":"387","author":"Soares","year":"2001","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jmb.2005.04.072_bib44","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1006\/abbi.1998.0853","article-title":"Immunochemical characterization and role in toxic activities of region 115\u2013129 of myotoxin II, a Lys49 phospholipase A2 from Bothrops asper snake venom","volume":"358","author":"Calder\u00f3n","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jmb.2005.04.072_bib45","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0041-0101(01)00141-6","article-title":"Identification of the myotoxic site of the Lys49 phospholipase A(2) from Agkistrodon piscivorus piscivorus snake venom: synthetic C-terminal peptides from Lys49, but not from Asp49 myotoxins, exert membrane-damaging activities","volume":"39","author":"N\u00fa\u00f1ez","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.jmb.2005.04.072_bib46","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1042\/bj20020092","article-title":"Distinct sites for myotoxic and membrane-damaging activities in the C-terminal region of a Lys49-phospholipase A2","volume":"366","author":"Chioato","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.jmb.2005.04.072_bib47","doi-asserted-by":"crossref","first-page":"21774","DOI":"10.1074\/jbc.M212833200","article-title":"Leads for development of new naphthalenesulfonate derivatives with enhanced antiangiogenic activity: crystal structure of acidic fibroblast growth factor in complex with 5-amino-2-naphthalene sulfonate","volume":"278","author":"Fernandez-Tornero","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2005.04.072_bib48","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1046\/j.1432-1327.1998.2530452.x","article-title":"Bactericidal activity of Lys49 and Asp49 myotoxic phospholipases A2 from Bothrops asper snake venom-synthetic Lys49 myotoxin II-(115\u2013129)-peptide identifies its bactericidal region","volume":"253","author":"P\u00e1ramo","year":"1998","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jmb.2005.04.072_bib49","series-title":"Venom Phospholipase A2 Enzymes: Structure, Function and Mechanism","first-page":"321","article-title":"Phospholipase A2 myotoxins from Bothrops snake venoms","author":"Guti\u00e9rrez","year":"1997"},{"key":"10.1016\/j.jmb.2005.04.072_bib50","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1107\/S0907444999004576","article-title":"Crystallization and preliminary X-ray diffraction studies of piratoxin III, a D-49 phospholipase A2 from the venom of Bothrops pirajai","volume":"55","author":"Lee","year":"1999","journal-title":"Acta Crystallog. sect. D"},{"key":"10.1016\/j.jmb.2005.04.072_bib51","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0041-0101(89)90039-1","article-title":"A new muscle damaging toxin, myotoxin II, from the venom of the snake Bothrops asper (terciopelo)","volume":"27","author":"Lomonte","year":"1989","journal-title":"Toxicon"},{"key":"10.1016\/j.jmb.2005.04.072_bib52","series-title":"Drug Discovery and Evaluation: Pharmacological Assays","first-page":"732","article-title":"Anesthesia of experimental animals","author":"Mass","year":"1997"},{"key":"10.1016\/j.jmb.2005.04.072_bib53","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0041-0101(98)00183-4","article-title":"Ability of wedelolactone, heparin, and para-bromophenacyl bromide to antagonize the myotoxic effects of two crotaline venoms and their PLA2 myotoxins","volume":"37","author":"Melo","year":"1999","journal-title":"Toxicon"},{"key":"10.1016\/j.jmb.2005.04.072_bib54","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bbapap.2004.08.009","article-title":"Crystallization and preliminary X-ray diffraction analysis of suramin, a highly charged polysulfonated napthylurea, complexed with a myotoxic PLA2 from Bothrops asper venom","volume":"1703","author":"Murakami","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jmb.2005.04.072_bib55","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collection in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jmb.2005.04.072_bib56","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1107\/S0108767393007597","article-title":"AMoRe: an automated package for molecular replacement","volume":"50","author":"Navaza","year":"1994","journal-title":"Acta Crystallog. sect. A"},{"key":"10.1016\/j.jmb.2005.04.072_bib57","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1107\/S0907444996012255","article-title":"Refinement of macromolecular structures by the maximum-likelihood method","volume":"53","author":"Murshudov","year":"1997","journal-title":"Acta Crystallog. sect. D"},{"key":"10.1016\/j.jmb.2005.04.072_bib58","series-title":"Silicon Graphics Geometry Partner Directory","first-page":"77","article-title":"Turbo-Frodo","author":"Roussel","year":"1989"},{"key":"10.1016\/j.jmb.2005.04.072_bib59","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Crystallog."}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002228360500505X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002228360500505X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,11]],"date-time":"2021-07-11T12:40:41Z","timestamp":1626007241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002228360500505X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S002228360500505X"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2005.04.072","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}